Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis
Clinical trial NCT02547922 · COMPLETED
Trial details
- NCT number
- NCT02547922
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-04
- Primary completion
- 2019-11-26
- Enrollment
- 147
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.